APA (7th ed.) Citation

de la Puente, E., Ramos-Mundo, C., Flores-Pérez, E. I., Vergara-Castañeda, A., Reyes-Grajeda, J. P., Medina-Reyes, L. J., . . . Loza-Mejía, M. A. (2025). Variations in Plasma Levels of Orally Administered Ivermectin Could Hamper Its Potential Drug Repositioning: Results of a Bioequivalence Study in Mexican Population. Pharmaceuticals (14248247), 18(8), 1193. https://doi.org/10.3390/ph18081193

Chicago Style (17th ed.) Citation

de la Puente, Ernesto, Carlos Ramos-Mundo, Elena I. Flores-Pérez, Arely Vergara-Castañeda, Juan Pablo Reyes-Grajeda, Liz J. Medina-Reyes, María Isabel Ruiz-Olmedo, and Marco A. Loza-Mejía. "Variations in Plasma Levels of Orally Administered Ivermectin Could Hamper Its Potential Drug Repositioning: Results of a Bioequivalence Study in Mexican Population." Pharmaceuticals (14248247) 18, no. 8 (2025): 1193. https://doi.org/10.3390/ph18081193.

MLA (9th ed.) Citation

de la Puente, Ernesto, et al. "Variations in Plasma Levels of Orally Administered Ivermectin Could Hamper Its Potential Drug Repositioning: Results of a Bioequivalence Study in Mexican Population." Pharmaceuticals (14248247), vol. 18, no. 8, 2025, p. 1193, https://doi.org/10.3390/ph18081193.